Baird Financial Group
DBTX

Baird Financial Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Baird Financial Group’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,900
Closed -$57.4K – 1783
2023
Q2 		$57.4K Hold
14,900
– – ﹤0.01% 1669
2023
Q1 		$45K Buy
+14,900
New +$51.5K ﹤0.01% 1669

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $914M AUM

Baird Financial Group's DBTX Position: Q3 2023 in Review

Baird Financial Group sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 14,900 shares — an estimated $57.4K sold.

Baird Financial Group first reported a position in DBTX in Q1 2023 and held it in 2 quarters. The position peaked at $57.4K in Q2 2023. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Baird Financial Group reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Baird Financial Group sold 14,900 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $57.4K.
  • Baird Financial Group first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Baird Financial Group's Decibel Therapeutics, Inc. Common Stock position peaked at $57.4K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Baird Financial Group's 13F filing for Q3 2023, filed 13 Nov 2023.